Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9016465 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2005 | 8 Pages |
Abstract
Findings suggest that a definition of mixed depression requiring 3 or more intra-MDE hypomanic symptoms may be a useful clinical marker for predicting the diagnosis of BP-II. Presence of mixed depression should lead to skillful probing for history of hypomania, which would probably reduce the BP-II misdiagnosed as MDD. Findings may also impact treatment of BP-II, as intra-MDE hypomanic symptoms may become more severe by antidepressants alone, and mood stabilising agents may be required before (or concurrently with) antidepressants.
Keywords
NPVROCPPVMDDBipolar-II disorderSCID-CVGAFMDEχ2Major depressive disorderpositive predictive valuenegative predictive valueGlobal Assessment of Functioning scaleDepressionMixed depressionSensitivitydegrees of freedomDepressive mixed stateconfidence intervalMajor depressive episodeodds ratioSpecificity
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Franco Benazzi,